Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Marked Hematologic Cancer Risk in Enlarged Spleens
January 2026
Individuals with large spleens face increased risk of hematologic cancer and liver disease, supporting the use of spleen size thresholds in clinical assessment.
Read more
12 Dec 2016
Sepsis-Induced Immune Paralysis Reversed by β-Glucan
SEPSIS is a life-threatening condition with inefficient treatment options available at present. With an incidence of approximately 2–30 per 10,000 people…
2 Dec 2016
EMJ Weekly News Round-Up: 1st December
Keeping you up to date with the latest news, we summarise a selection of stories from us here at EMJ and from across the web that you might have missed…
30 Nov 2016
Orchard Therapeutics Announces Strategic Alliance with Oxford BioMedica
United Kingdom, November 29, 2016 – Orchard Therapeutics (“Orchard”), a biotechnology company dedicated to bringing transformative ex-vivo gene therapies…
25 Nov 2016
EMJ Weekly News Round-Up: 25th November
A selection of stories from us here at EMJ and from across the web that you might have missed during the week.
13 Oct 2016
Introducing EMJ Cardiology 4.1
Welcome to EMJ Cardiology 4.1, the go-to place for emerging academic and clinical research in the sphere of cardiology. This edition offers a number of…
19 Sep 2016
CRISPR Genome Editing Allows Blood Cells to Resist Sickle Cell Disease
INNOVATIVE CRISPR genome editing has been used to inhibit the pathological morphology of red blood cells caused by sickle cell disease, offering a new…
12 Jul 2016
Introducing EMJ Neurology 4.1
Welcome to EMJ Neurology 4.1, an edition filled with informative and engaging content which spotlights the latest research and developments in the field…
22 Jun 2016
iVascular Receives CE Mark Approval for LUMINOR 18 Drug Eluting Balloon
May 16, 2016 – LUMINOR 18, which is 0.018 Guide Wire compatible, is added to the existing LUMINOR range (Luminor14 and Luminor35), to offer the only…
Loading posts...
« Previous
1
…
40
41
42
43
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View